Expertise in
3
conditions

Mariusz M. Klopotowski

Alpejska 42 Street, 
Warsaw, MZ, PL 
Expertise in
3
conditions
Alpejska 42 Street, 
Warsaw, MZ, PL 

Overview

Mariusz Klopotowski practices practicing medicine in Warsaw, Poland.

Mr. Klopotowski is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Fabry Disease, Percutaneous Coronary Intervention (PCI), and Cardiac Ablation.

He is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Alpejska 42 Street, Warsaw, MZ 04628, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy
The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy
Enrollment Status: Active_not_recruiting
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: Empagliflozin
Study Phase: Phase 3
A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects With Fabry Disease
A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects With Fabry Disease
Enrollment Status: Terminated
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drug: Replagal
Study Phase: Phase 3
View 1 Less Clinical Trial

55 Total Publications

Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.
Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.
Journal: American heart journal
Published: February 13, 2026

Frequently Asked Questions about Mariusz M. Klopotowski

Is Mariusz M. Klopotowski a top-rated expert for Hypertrophic Cardiomyopathy (HCM)?

MediFind is an objective health platform that identifies experts based on real-world data. Mariusz M. Klopotowski is classified as an Distinguished expert for Hypertrophic Cardiomyopathy (HCM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mariusz M. Klopotowski participate in research or clinical trials?

Yes. Mariusz M. Klopotowski has published 55 articles and abstracts on conditions like Hypertrophic Cardiomyopathy (HCM). You can view a list of Mariusz M. Klopotowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Klopotowski's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile